Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TRULICITY
- GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery
- A Study of LY3532226 in Participants With Type 2 Diabetes Mellitus
- Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2D
- The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.
- GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response
- Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients
- A Study Comparing the Dulaglutide Pen and the Semaglutide Pen
- Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)
- Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes
- Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
- Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study)
- A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin
Clinical trials list
click for details